Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Novus Medical Detox Center Extols Surgeon General’s Leadership in Battling U.S Opioid Epidemic
  • USA - English


News provided by

JoTo PR

Sep 12, 2016, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Bryn Wesch, CFO of Novus Medical Detox Center, comments on the Surgeon Generals call to action for practitioners regarding opioids.
Bryn Wesch, CFO of Novus Medical Detox Center, comments on the Surgeon Generals call to action for practitioners regarding opioids.

By pinpointing addiction and dependency as a chronic medical disorder, the Surgeon General is helping many to realize the physiological component of this health issue.

Post this

NEW PORT RICHEY, Fla. (PRWEB) September 12, 2016 -- Nearly 2 million Americans currently have a prescription opioid use disorder (1), while opioid overdose deaths have risen to 78 per day (2)—leading U.S. Surgeon General Vivek Murthy to appeal to healthcare professionals nationwide to join together in combating the health crisis. Murthy recently sent letters to America’s 2.3 million prescribers to enlist their commitment and cooperation in addressing the epidemic.(1) Novus Medical Detox Center, a leading Florida-based drug treatment facility, regards the move as a potential game-changer for individuals with opioid use disorders, and hopes Murthy’s efforts will garner greater support for prevention, treatment and recovery.

Earlier this year, Murthy announced his intent to reach out to prescribers. He noted that early-1990s training materials claimed “addiction to opioids is very rare in patients who have [legitimate] pain,” and said many clinicians’ prescribing practices are still based on those erroneous teachings.(3) His letter asks healthcare providers to do three things:

1. Sharpen their prescribing practices and educate themselves on how to treat pain safely and effectively.
2. Screen patients for opioid use disorder and connect them with evidence-based treatment.
3. Shape how the public views addiction by talking about it as a chronic illness rather than a moral failing.(1)

Along with each letter, Murthy enclosed a pocket card that outlines key recommendations from the CDC Opioid Prescribing Guideline. The materials emphasize that opioids should not be prescribed as first-line treatment for chronic pain, and direct healthcare professionals to first consider alternate treatments such as non-addictive medications, physical therapy or cognitive behavioral therapy. They also advise clinicians to “start low and go slow” when prescribing opioids and to “assess, tailor and taper” prescriptions within several weeks.(4)

Bryn Wesch, CFO of Novus Medical Detox Center, applauds Murthy’s initiative and is optimistic that it will create positive changes for those suffering from addiction and dependency. “The Surgeon General acknowledges that many healthcare providers have been misled as to the risk of opioid addiction. Rather than blaming or chastising prescribers, he urges them to explore new ways to safely treat chronic pain and to help those with opioid use disorders obtain proper treatment,” she explained. “He also aims to remove the stigma associated with substance use disorders, which should help empower individuals and families affected by opioids to request the support they need.”

Murthy has asserted that there is “a major treatment gap in this country that we have to close”.(1) While the Obama administration has sought to improve access to treatment, additional funding and education will be required.(3) However, Wesch believes that if prescribers unite in support of Murthy’s proposals, patients who are addicted to or dependent on opioids will finally be identified, assisted and referred for treatment rather than shamed or vilified.

“By pinpointing addiction and dependency as a chronic medical disorder, the Surgeon General is helping many to realize the physiological component of this health issue,” said Wesch. “It’s not simply a matter of quitting opioid use. Many patients need medically supervised treatment to help them overcome the physical pain and discomfort of withdrawal before they can achieve successful long-term recovery, and they also need to be prescribed safer alternatives for chronic pain.”

Novus offers medically supervised drug detox programs that help patients overcome dependency and addiction by minimizing the discomfort of opiate and opioid withdrawal. The Florida drug detox facility individually customizes each patient’s treatment plan based on proven medical protocols, including 24-hour access to nursing care and withdrawal specialists. Novus is acclaimed for its expertise in treating high-dose methadone cases, and is proficient in detoxing patients from other high-dose opioids just as comfortably, safely and effectively.

For more information on Novus Medical Detox Center and its opioid detox and treatment programs, visit http://www.novusdetox.com.

About Novus Medical Detox Center:
Novus Medical Detox Center has earned The Joint Commission’s Gold Seal of Approval for Behavioral Health Care Accreditation as an inpatient medical detox facility. Licensed by the Florida Department of Children and Families, Novus provides safe, effective alcohol and drug treatment programs that are based on proven medical protocols and designed to minimize the discomfort of withdrawal. The facility is located on 3.25 acres in New Port Richey, Florida, in a tranquil, spa-like setting bordering protected conservation land. Intent on proving that detox doesn’t have to be painful or degrading, Novus set out to transform the industry by bringing humanity into medical detox with individually customized treatment programs and 24/7 access to nursing care and withdrawal specialists. Today, Novus is renowned as a champion of industry standardization and a staunch advocate of patients fighting to overcome substance use disorders. Frequently recognized for its contributions to the industry and local community, Novus has become a regular source to media publications such as The Wall Street Journal and USA Today, and has ranked in the Tampa Bay Business Journal’s Fast 50, the Florida Business Journal’s Top 500 and the Inc. 5000 list of America’s fastest-growing companies. For more information on Novus’ medically supervised detox programs, visit http://novusdetox.com.

1. CBS News. “Surgeon General Takes Unprecedented Step Amid Opioid Epidemic”; CBS This Morning; August 25, 2016. cbsnews.com/news/vivek-murthy-surgeon-general-opiods-health-crisis-letter-clinicians-zika/

2. Centers for Disease Control and Prevention. “Understanding the Epidemic: Record Overdose Deaths”; Opioid Overdose data on CDC website; last updated June 21, 2016. cdc.gov/drugoverdose/epidemic/

3. Kenen, Joanne. “Surgeon General Uses Bully Pulpit to Combat Opioid Crisis”; Politico; April 8, 2016. politico.com/story/2016/04/surgeon-general-uses-bully-pulpit-to-combat-opioid-crisis-221720

4. U.S. Department of Health and Human Services and Surgeon General of the United States. Prescribing Opioids for Chronic Pain; pocket card published on TurnTheTideRx.com; August 2016. turnthetiderx.org/treatment/

Karla Jo Helms, JoTo PR, +1 (888) 202-4614 Ext: 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.